Medicinecounter · Newsroom

Ivermectin Remains in Global Focus as U.S. Patients Seek Clear Guidance and Licensed Access
Ivermectin’s Nobel Prize history and global research attention continue to spark public interest. U.S. patients seek licensed, legal access for its FDA-approved antiparasitic use.

December 8, 2025

Ivermectin’s Online Evolution: A Decade of Debate, Discovery, and Renewed Interest
Ivermectin has gained ongoing attention across social media due to its Nobel Prize history and medical background. Medicine Counter provides clear, verified information and responsible access for prescribed uses.

November 26, 2025